» Articles » PMID: 37223035

Associations Between Urinary Iodine Concentration and the Prevalence of Metabolic Disorders: a Cross-sectional Study

Overview
Specialty Endocrinology
Date 2023 May 24
PMID 37223035
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Few studies have examined the role of iodine in extrathyroidal function. Recent research has shown an association between iodine and metabolic syndromes (MetS) in Chinese and Korean populations, but the link in the American participants remains unknown.

Purpose: This study aimed to examine the relationship between iodine status and metabolic disorders, including components associated with metabolic syndrome, hypertension, hyperglycemia, central obesity, triglyceride abnormalities, and low HDL.

Methods: The study included 11,545 adults aged ≥ 18 years from the US National Health and Nutrition Examination Survey (2007-2018). Participants were divided into four groups based on their iodine nutritional status(ug/L), as recommended by the World Health Organization: low UIC, < 100; normal UIC, 100-299; high UIC, 300-399; and very high, ≥ 400. The Odds ratio (OR) for MetS basing the UIC group was estimated using logistic regression models for our overall population and subgroups.

Results: Iodine status was positively associated with the prevalence of MetS in US adults. The risk of MetS was significantly higher in those with high UIC than in those with normal UIC [OR: 1.25; 95% confidence intervals (CI),1.016-1.539; = 0.035). The risk of MetS was lower in the low UIC group (OR,0.82; 95% CI: 0.708-0.946; = 0.007). There was a significant nonlinear trend between UIC and the risk of MetS, diabetes, and obesity in overall participants. Participants with high UIC had significantly increased TG elevation (OR, 1.24; 95% CI: 1.002-1.533; = 0.048) and participants with very high UIC had significantly decreased risk of diabetes (OR, 0.83; 95% CI: 0.731-0.945, = 0.005). Moreover, subgroup analysis revealed an interaction between UIC and MetS in participants aged < 60 years and ≥ 60 years, and no association between UIC and MetS in older participants aged ≥ 60 years.

Conclusion: Our study validated the relationship between UIC and MetS and their components in US adults. This association may provide further dietary control strategies for the management of patients with metabolic disorders.

Citing Articles

Global burden and cross-country inequalities of nutritional deficiencies in adults aged 65 years and older, 1990-2021: population-based study using the GBD 2021.

Liang S, Xi S, Liu J, Tang G, Zhang W, Guo X BMC Geriatr. 2025; 25(1):74.

PMID: 39893435 PMC: 11786432. DOI: 10.1186/s12877-025-05728-9.


Association of "a body shape index" with the risk of developing colorectal cancer in U.S. patients with metabolic syndrome: evidence from the NHANES 1999-2018.

Kurexi A, Peng J, Yao J, Wang L, Wang Q BMC Gastroenterol. 2024; 24(1):447.

PMID: 39627686 PMC: 11613469. DOI: 10.1186/s12876-024-03537-9.


The correlation between urinary iodine levels and gallstone risk: elevated iodine intake linked to gallstone occurrence.

Li Y, Wang M, Du W, Qi L, Liu X, Fan X Front Nutr. 2024; 11:1412814.

PMID: 39114128 PMC: 11303756. DOI: 10.3389/fnut.2024.1412814.


Micronutrient status and protein-energy malnutrition in free-living older adults: a current perspective.

Alvarez-Nuncio M, Ziegler T Curr Opin Gastroenterol. 2024; 40(2):99-105.

PMID: 38193299 PMC: 10872245. DOI: 10.1097/MOG.0000000000001000.


Iodine Intake and Testosterone.

Barbonetti A, Castellini C, Di Giulio F, Antolini F, Tienforti D, Muselli M JAMA Netw Open. 2023; 6(12):e2348573.

PMID: 38117501 PMC: 10733805. DOI: 10.1001/jamanetworkopen.2023.48573.

References
1.
Leung A, Braverman L . Consequences of excess iodine. Nat Rev Endocrinol. 2013; 10(3):136-42. PMC: 3976240. DOI: 10.1038/nrendo.2013.251. View

2.
Malik S, Wong N, Franklin S, Kamath T, LItalien G, Pio J . Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults. Circulation. 2004; 110(10):1245-50. DOI: 10.1161/01.CIR.0000140677.20606.0E. View

3.
Mikulska A, Filipowicz D, Glowka F, Szczepanek-Parulska E, Ruchala M, Bartecki M . HPLC Analysis of the Urinary Iodine Concentration in Pregnant Women. Molecules. 2021; 26(22). PMC: 8619590. DOI: 10.3390/molecules26226797. View

4.
Lee K, Shin D, Song W . Low Urinary Iodine Concentrations Associated with Dyslipidemia in US Adults. Nutrients. 2016; 8(3):171. PMC: 4808899. DOI: 10.3390/nu8030171. View

5.
Andersson M, Braegger C . The Role of Iodine for Thyroid Function in Lactating Women and Infants. Endocr Rev. 2022; 43(3):469-506. PMC: 9113141. DOI: 10.1210/endrev/bnab029. View